Is Individual Operator Experience Important in TAVR?

Courtesy of Dr. Carlos Fava.

Transcatheter aortic valve replacement (TAVR) has emerged as a successful alternative for inoperable patients and a non-inferior alternative for high- and intermediate-risk patients. While its evolution depending on site experience has been analyzed, there is currently very little information regarding the impact of operator individual experience.

Terapia endovascular en stroke: mucha evidencia y pocos operadores entrenadosThis study analyzed 8771 procedures performed by 207 different operators. High-volume operators were defined as those performing ≥80 procedures/year; intermediate-volume operators were those performing between 24 and 79 procedures/year, and low-volume operators, <24 procedures/year. The “learning curve” of these operators was excluded so as to mitigate the incidence of complications that could bias results.

 

Patients of high-volume operators had a significantly lower in-hospital risk for death, stroke, and acute myocardial infarction (odds ratio: 0.59; 95% confidence interval [CI]: 0.37 to 0.93) compared with low-volume operators.


Read also: PCI Mortality and Volume in One Center: Associated?


Patients of operators who performed >200 procedures during the prior year had a significantly lower risk for post-procedural stroke (odds ratio: 0.41; 95% confidence interval: 0.17 to 0.97) and less in-hospital events (odds ratio: 0.45; 95% confidence interval: 0.26 to 0.78).

 

Conclusion

Increased operator experience is associated with improvement in risk-adjusted in-hospital progress. These results are potentially important for individual training and hospital programs in TAVR.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Individual Operator Experience and Outcomes in Transcatheter Aortic Valve Replacement.

Reference: Arash Salemi et al. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....